Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash	$ 337	$ 1,210
Prepaid expenses	0	746
Total current assets	337	1,956
Other assets, net	91,464	116,495
Patents, net	393,990	445,018
Total assets	485,791	563,469
CURRENT LIABILITIES:
Accounts payable	519,899	323,948
Convertible notes, net of discount $35,525 and $39,414 respectively	931,158	1,033,249
Derivative liability	1,220,877	1,275,500
Accrued Liabilities	569,970	497,078
Contract liability, related party	0	42,000
Related party notes payable	0	44,096
Total current liabilities	3,241,904	3,215,871
Secured Debenture	1,176,092	1,155,150
Total liabilities	4,417,996	4,371,021
Commitments and contingencies	0	0
STOCKHOLDERS' DEFICIT
Convertible preferred stock - Class D (par value $0.01; 100,000 shares authorized; 88,235 issued and outstanding at December 31, 2020 and, 2019, respectively)	883	883
Common stock (par value $0.0001), 20,000,000,000 shares authorized, 4,088,762,151 and 1,392,042,112 shares issued and outstanding at December 31, 2020 and, 2019, respectively	408,876	13,920,421
Treasury stock, 100,000 shares at December 31, 2020 and December 31, 2019	(1,000)	(1,000)
Paid-in capital in excess of par value	1,805,813	(11,877,864)
Non-controlling interest in a variable interest entity and subsidiary	(12,439)	(12,439)
Accumulated other comprehensive income	315,832	336,775
Accumulated deficit	(6,450,170)	(6,174,328)
TOTAL STOCKHOLDERS' DEFICIT	(3,932,205)	(3,807,552)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 485,791	$ 563,469